Related references
Note: Only part of the references are listed.High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
Isabelle Janoueix-Lerosey et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Uniparental disomy in cancer
Musaffe Tuna et al.
TRENDS IN MOLECULAR MEDICINE (2009)
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors:: Four cases of homozygous deletions of the CDKN2A gene
Helena Caren et al.
BMC GENOMICS (2008)
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature
N. Tomioka et al.
ONCOGENE (2008)
ArrayCGH-based classification of neuroblastoma into genomic subgroups
Evi Michels et al.
GENES CHROMOSOMES & CANCER (2007)
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Yael P. Mosse et al.
GENES CHROMOSOMES & CANCER (2007)
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization
Paola Scaruffi et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays
Go Yamamoto et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
Rani E. George et al.
PLOS ONE (2007)
High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays
Jane Carr et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome
Ruediger Spitz et al.
GENES CHROMOSOMES & CANCER (2006)
Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients
Eiso Hiyama et al.
JOURNAL OF PEDIATRIC SURGERY (2006)
Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH
RR Selzer et al.
GENES CHROMOSOMES & CANCER (2005)
High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma
QR Chen et al.
CANCER LETTERS (2005)
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays
Y Nannya et al.
CANCER RESEARCH (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons
K De Preter et al.
BMC GENOMICS (2004)
Clonal expansion and not cell interconversion is the basis for the neuroblast and nonneuronal types of the SK-N-SH neuroblastoma cell line
N Cohen et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines
N Van Roy et al.
GENES CHROMOSOMES & CANCER (2001)